Unknown

Dataset Information

0

Modification of the loops in the ligand-binding site turns avidin into a steroid-binding protein.


ABSTRACT: BACKGROUND: Engineered proteins, with non-immunoglobulin scaffolds, have become an important alternative to antibodies in many biotechnical and therapeutic applications. When compared to antibodies, tailored proteins may provide advantageous properties such as a smaller size or a more stable structure. RESULTS: Avidin is a widely used protein in biomedicine and biotechnology. To tailor the binding properties of avidin, we have designed a sequence-randomized avidin library with mutagenesis focused at the loop area of the binding site. Selection from the generated library led to the isolation of a steroid-binding avidin mutant (sbAvd-1) showing micromolar affinity towards testosterone (Kd ~ 9 ?M). Furthermore, a gene library based on the sbAvd-1 gene was created by randomizing the loop area between ?-strands 3 and 4. Phage display selection from this library led to the isolation of a steroid-binding protein with significantly decreased biotin binding affinity compared to sbAvd-1. Importantly, differential scanning calorimetry and analytical gel-filtration revealed that the high stability and the tetrameric structure were preserved in these engineered avidins. CONCLUSIONS: The high stability and structural properties of avidin make it an attractive molecule for the engineering of novel receptors. This methodology may allow the use of avidin as a universal scaffold in the development of novel receptors for small molecules.

SUBMITTER: Riihimaki TA 

PROVIDER: S-EPMC3201017 | biostudies-literature | 2011

REPOSITORIES: biostudies-literature

altmetric image

Publications

Modification of the loops in the ligand-binding site turns avidin into a steroid-binding protein.

Riihimäki Tiina A TA   Hiltunen Soili S   Rangl Martina M   Nordlund Henri R HR   Määttä Juha A E JA   Ebner Andreas A   Hinterdorfer Peter P   Kulomaa Markku S MS   Takkinen Kristiina K   Hytönen Vesa P VP  

BMC biotechnology 20110609


<h4>Background</h4>Engineered proteins, with non-immunoglobulin scaffolds, have become an important alternative to antibodies in many biotechnical and therapeutic applications. When compared to antibodies, tailored proteins may provide advantageous properties such as a smaller size or a more stable structure.<h4>Results</h4>Avidin is a widely used protein in biomedicine and biotechnology. To tailor the binding properties of avidin, we have designed a sequence-randomized avidin library with mutag  ...[more]

Similar Datasets

| S-EPMC3029397 | biostudies-literature
| S-EPMC2527462 | biostudies-literature
| S-EPMC2797287 | biostudies-literature
| S-EPMC5311481 | biostudies-literature
| S-EPMC7049599 | biostudies-literature
| S-EPMC3180581 | biostudies-literature
| S-EPMC1217322 | biostudies-other
| S-EPMC1347425 | biostudies-literature
| S-EPMC3324516 | biostudies-literature
| S-EPMC6115637 | biostudies-literature